Details for Patent: 12,016,875
✉ Email this page to a colleague
Which drugs does patent 12,016,875 protect, and when does it expire?
Patent 12,016,875 protects IZERVAY and is included in one NDA.
This patent has thirty-two patent family members in fifteen countries.
Drugs Protected by US Patent 12,016,875
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astellas | IZERVAY | avacincaptad pegol sodium | SOLUTION;INTRAVITREAL | 217225-001 | Aug 4, 2023 | RX | Yes | Yes | 12,016,875 | ⤷ Subscribe | TREATMENT OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION BY ADMINISTERTING AVACINCAPTAD PEGOL TO THE EYE | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,016,875
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014286996 | ⤷ Subscribe | |||
| Australia | 2020201824 | ⤷ Subscribe | |||
| Australia | 2022201404 | ⤷ Subscribe | |||
| Australia | 2024200948 | ⤷ Subscribe | |||
| Brazil | 112016000546 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
